Please assess the completion status of the following clinical trial:

Trial Title: Hemodynamic Effect of Lumbosacral Plexus Blockade Versus Spinal Anesthesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients for total hip replacement at Aarhus University Hospital~* Age \>= 50 years~* American Society of Anesthesiologists physical status classification score I-III~* Informed consent~Exclusion Criteria:~* Lack of ability to cooperate~* Lack of ability to speak Danish~* Chronic pain, that demands opioid treatment. Not inkl. hip pain.~* Previous venous thromboembolic event~* Previous major back surgery~* Severe cardiopulmonary disease (NYHA class 4)~* Severe untreated hypertension (systolic blood pressure \> 160 mm Hg or diastolic blood pressure \> 110 mm Hg)~* Obesity (BMI \> 35 kg/m\^2)~* Pregnancy~* Allergy towards the used local analgetics~* Current treatment with amiodarone or verapamil

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lumbosacral plexus blockade (Type: EXPERIMENTAL): Peripheral nerve blockade of lumbar and sacral plexus with ropivacaine max 225 mg perineural
- Continuous spinal anesthesia (Type: ACTIVE_COMPARATOR): Continuous spinal anesthesia with plain bupivacaine max 15 mg intrathecal

Based on this trial design, predict the completion outcome and termination type (if applicable).